Well - no matter the results, MVF have a powerful group of Specialists inside the business who can extract a significant share of the earnings if they put their minds to it. Adds a layer of risk IMO. I remember VEI (or VGH) many years ago had a major tussle with their specialists, and never really performed as was initially expected. MVF on some metrics seems good value, but on reflection I don't understand the balance of power issues. VRT is another that could suffer similarly. If this issue was nailed down somehow, I would be very interested.
I'm not sure if gaining capital is a major difficulty, if the specialists strike out on their own.
News: MVF Monash IVF Group Posts FY Net Profit Attributable $21.4 Mln, page-6
Add MVF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.010(0.90%) |
Mkt cap ! $465.6M | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.15 | $1.11 | $900.2K | 804.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 26466 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 71309 | 6 |
View Market Depth
| Last trade - 14.58pm 19/11/2024 (20 minute delay) ? |
| MVF (ASX) Chart |
